ARTICLE | Clinical News
Atrix starts Phase III
April 18, 2001 7:00 AM UTC
ATRX began a Phase III trial of Atrisone dapsone, an antibiotic and anti-inflammatory sulfone small molecule for the topical treatment of moderate to severe acne. Atrisone incorporates ATRX's SMP tech...